157749 people have viewed this drug in the last 60 days
Updated 2025-08-12
| Last Update | 2022-08-31 |
| Register Year | 2017 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | BLINATUMOMAB |
| Trade Name | BLINCYTO |
| Strength Unit | µg |
| Pharmaceutical Form | Powder for concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | L01XC |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $10495.25 |
| Shelf Life | 60 Months |
| Marketing Company | Amgen Inc. |
| Marketing Country | United States |
| Manufacture Name | Boehringer Ingelheim Pharma GmbH & Co. KG |
| Manufacture Country | Germany |
| Secondry package manufacture | |
| Main Agent | Salehiya Trading Co. |
| Secosnd Agent | |
| Third Agent | |
| Visits | 157749 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| BLINCYTO | $10495.25 | 157749 visits | 2022-08-31 |